Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,941,529
+$3,378,640 QoQ
Shares Held
85,110
+89.0% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 239 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026READYSTATE ASSET MANAGEMENT LP holds $170,733,904 across 15 Biotechnology names. NKTR ranks #10 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMNM |
Immunome Inc.
|
1,605,820 | $34,027,325 | |
| 2 | ABVX |
Abivax S.A.
|
241,530 | $32,186,287 | |
| 3 | WVE |
Wave Life Sciences, Inc.
|
4,727,139 | $27,464,677 | |
| 4 | QURE |
uniQure N.V.
|
400,989 | $18,469,553 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
295,114 | $12,663,341 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
156,090 | $9,073,511 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
33,554 | $8,213,012 | |
| 8 | OLMA |
Olema Pharmaceuticals, Inc.
|
593,829 | $7,428,800 |
All Filings in NKTR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,941,529 | 85,110 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $2,562,889 | 45,042 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||